Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thyroid Neoplasm
|
135 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 5 | 2007 | 2016 | ||||||
Neoplasms
|
1644 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.730 | 1.000 | 4 | 2014 | 2017 | ||||||
Squamous cell carcinoma of skin
|
92 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 4 | 2012 | 2016 | ||||||
Medullary carcinoma of thyroid
|
71 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||
melanoma
|
515 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.720 | 1.000 | 2 | 2016 | 2018 | ||||||
Papillary thyroid carcinoma
|
204 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of pancreas
|
138 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of prostate
|
108 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adrenal Gland Pheochromocytoma
|
50 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinoma
|
103 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Carcinoma of lung
|
1204 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Chronic Lymphocytic Leukemia
|
291 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Colorectal Neoplasms
|
609 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Cutaneous Melanoma
|
248 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Dysplastic Nevus
|
7 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Eccrine porocarcinoma
|
11 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Familial medullary thyroid carcinoma
|
45 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Follicular Variant Thyroid Gland Papillary Carcinoma
|
13 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Gastric Adenocarcinoma
|
235 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Inverted urothelial papilloma
|
3 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Leukemia, Myelocytic, Acute
|
6892 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Liver carcinoma
|
942 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Mammary Neoplasms
|
385 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 |